Massachusetts Institute of Technology Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
VIOT
Viomi Technology
VIOT
|
+$166K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
JBGS
JBG SMITH
JBGS
|
+$17M |
| 2 |
Editas Medicine
EDIT
|
+$1.42M |
| 3 |
ONC
BeOne Medicines Ltd
ONC
|
+$337K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 56.23% |
| 2 | Real Estate | 43.58% |
| 3 | Consumer Discretionary | 0.2% |
| 4 | Healthcare | 0% |
Similar funds
Massachusetts Institute of Technology's Q4 2019 Portfolio in Review
As of Q4 2019, Massachusetts Institute of Technology held 6 positions worth $78.7M, down 16% from $94.2M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Massachusetts Institute of Technology withdrew a net $18.6M in Q4 2019, closing 2 positions and reducing 1 holding. Its most notable exit was Editas Medicine, an estimated $1.42M position sold in full.
By sector, the portfolio is most concentrated in Industrials at 56% of assets, up from 44% a quarter earlier, followed by Real Estate and Consumer Discretionary.
Against the trend, Massachusetts Institute of Technology opened a new position in Viomi Technology worth $155K.
- Massachusetts Institute of Technology's largest Q4 2019 buy was Viomi Technology: 19,252 shares worth $155K.
- Massachusetts Institute of Technology's biggest Q4 2019 reduction was JBG SMITH, cutting an estimated $17M.
- Massachusetts Institute of Technology fully exited Editas Medicine in Q4 2019, selling an estimated $1.42M.
- Massachusetts Institute of Technology's ten largest holdings make up 100% of its $78.7M portfolio in Q4 2019.
- Massachusetts Institute of Technology opened 1 new position and closed 2 in Q4 2019.
- Massachusetts Institute of Technology's portfolio value fell 16% quarter-over-quarter to $78.7M.
Based on Massachusetts Institute of Technology's 13F filing for Q4 2019, filed 13 Feb 2020.